- Home
- VRE vs PRGO Comparison
VRE vs PRGO Comparison
Compare VRE & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRE | PRGO |
|---|---|---|
| Founded | 1949 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | VRE | PRGO |
|---|---|---|
| Price | $19.00 | $11.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $19.50 | $19.33 |
| AVG Volume (30 Days) | 701.6K | ★ 2.2M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | 1.69% | ★ 10.28% |
| EPS Growth | ★ 420.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $288,434,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.87 | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.40 | N/A |
| 52 Week Low | $13.69 | $9.23 |
| 52 Week High | $19.03 | $28.44 |
Technical Indicators
Market Signals| Indicator | VRE | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 67.08 | 48.94 |
| Support Level | $18.88 | $10.46 |
| Resistance Level | $19.01 | $12.36 |
| Average True Range (ATR) | 0.02 | 0.49 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 92.86 | 30.34 |
Price Performance
Historical ComparisonAbout VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.